Yaling Han

Research interests

Publications

• Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

  New England Journal of Medicine · 2022 · https://doi.org/10.1056/nejmoa2206286

• Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

  JACC Heart Failure · 2022 · https://doi.org/10.1016/j.jchf.2021.11.006

• Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial

  European Heart Journal · 2020 · https://doi.org/10.1093/eurheartj/ehaa543

• COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

  Nature Reviews Cardiology · 2020 · https://doi.org/10.1038/s41569-020-0413-9

• Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations

  Nature Communications · 2017 · https://doi.org/10.1038/ncomms15290

• Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions

  Journal of the American College of Cardiology · 2017 · https://doi.org/10.1016/j.jacc.2017.09.1066

• Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

  JAMA · 2015 · https://doi.org/10.1001/jama.2015.2323

• ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

  European Heart Journal · 2015 · https://doi.org/10.1093/eurheartj/ehu523

• Observation of e + e − → γ X ( 3872 ) at BESIII

  Physical Review Letters · 2014 · https://doi.org/10.1103/physrevlett.112.092001

Current projects

No projects listed.